Search results for "eps"

showing 10 items of 1777 documents

Mr-Proadm Elevation Upon Icu Admission Predicts the Outcome of Septic Patients and is Correlated with Upcoming Fluid Overload.

2017

IF 3.113; International audience; Background: Among septic patients admitted to the intensive care unit (ICU), early recognition of those with the highest risk of death is of paramount importance. We evaluated the prognostic value of Procalcitonin (PCT), mid regional-proadrenomedullin (MR-proADM), copeptine and CT-proendothelin 1 (CT-ProET 1) concentrations. Methods: This was a prospective cohort study, which included 173 septic patient admitted to one ICU. Blood samples for biomarker measure-ments were obtained upon admission and on day 5. The predictive value of each biomarker regarding the risk of death at day 28 was assessed. The fluid balance was evaluated from admission to day 5. Resu…

CalcitoninMalemedicine.medical_specialtyTime FactorsArbitrary unit030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineProcalcitoninDisease-Free Survivallaw.inventionSepsis03 medical and health sciencesAdrenomedullin0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemlawInternal medicineSepsismedicine[ SDV.MHEP.HEM ] Life Sciences [q-bio]/Human health and pathology/HematologyHumansHospital MortalityProtein PrecursorsProspective cohort studyAgedAged 80 and overEndothelin-1business.industryGlycopeptides[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology030208 emergency & critical care medicine[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemMiddle Agedmedicine.diseaseIntensive care unit3. Good healthSurgeryIcu admissionFluid balanceClinical trialHospitalizationIntensive Care UnitsEmergency MedicineproadrenomedullinBiomarker (medicine)FemalebusinessprocalcitoninBiomarkersShock (Augusta, Ga.)
researchProduct

Procalcitonin and community-acquired pneumonia (CAP) in children

2015

The role of procalcitonin (PCT) as a biomarker for sepsis in adults is well documented, while its role in infections affecting neonatal children remains controversial. Among these infections, Community-Acquired pneumonia (CAP) has been studied extensively, because it's the second cause of death in children in developing countries, and one of the most frequent causes of hospitalization in industrialized countries. The PubMed database and the Cochrane Library were used to search for the following keywords: CAP, procalcitonin, and children. Thirteen articles were studied to determine the role of PCT in CAP management, specifically its usefulness for distinguishing pneumococcal infections from …

Calcitoninmedicine.medical_specialtyCommunity-acquired pneumoniaCalcitonin Gene-Related PeptideClinical BiochemistryCochrane LibraryBiochemistryProcalcitoninSepsisCommunity-acquired pneumoniamedicineHumansProtein PrecursorsChildIntensive care medicineChildrenCause of deathPediatric CAPbusiness.industryBiochemistry (medical)BiomarkerGeneral MedicinePneumonia Pneumococcalmedicine.diseaseAnti-Bacterial AgentsCommunity-Acquired InfectionsBiomarkers; Children; Community-acquired pneumonia; PCT; Pediatric CAP; ProcalcitoninPneumoniaPneumococcal infectionsBiomarker (medicine)PCTbusinessProcalcitoninBiomarkershormones hormone substitutes and hormone antagonistsClinica Chimica Acta
researchProduct

Mineralization of SaOS-2 cells on enzymatically (silicatein) modified bioactive osteoblast-stimulating surfaces.

2005

There is a demand for novel bioactive supports in surgery, orthopedics, and tissue engineering. The availability of recombinant silica-synthesizing enzyme (silicatein) opens new possibilities for the synthesis of silica-containing bioactive surfaces under ambient conditions that do not damage biomolecules like proteins. Here it is shown that growth of human osteosarcoma SaOS-2 cells on cluster plates precoated with Type 1 collagen is not affected by additional coating of the plates with the recombinant silicatein and incubation with its enzymatic substrate, tetraethoxysilane (TEOS). However, the enzymatic modification of the plates by biosilica deposition on the protein-coated surface cause…

Calcium PhosphatesMaterials scienceSurface PropertiesBiomedical Engineeringchemistry.chemical_elementBiocompatible MaterialsCalciumMineralization (biology)Collagen Type Ilaw.inventionSubstrate SpecificityBiomaterialsCalcification PhysiologicTissue engineeringIn vivolawCell Line TumormedicineHumansSaos-2 cellsOsteoblastsOsteoblastSilanesCathepsinsIn vitroRecombinant Proteinsmedicine.anatomical_structurechemistryBiochemistryRecombinant DNAJournal of biomedical materials research. Part B, Applied biomaterials
researchProduct

Abstract 4246: Associations of Epstein-Barr virus (EBV)-positive gastric cancer with circulating mediators of inflammation and immune response

2017

Abstract Epstein-Barr virus (EBV) positivity defines one of four major molecular types of gastric cancer in The Cancer Genome Atlas (TCGA). However, viral status is not routinely determined in clinical practice and tumor samples are not generally collected in epidemiologic research. Histologically, EBV-positive gastric cancer is characterized by prominent inflammatory infiltrate. In molecular analyses from TCGA, EBV-positive gastric cancer had significantly higher expression of several chemokines, chemokine receptors and programmed death-ligand 1 (PD-L1) as compared to other molecular types combined. We hypothesized that EBV tumor status may also be reflected in profiles of circulating chem…

Cancer ResearchChemokinebiologybusiness.industryInflammationIn situ hybridizationmedicine.disease_causeEpstein–Barr virusVirusTumor StatusChemokine receptorImmune systemOncologyImmunologybiology.proteinMedicinemedicine.symptombusinessCancer Research
researchProduct

From a Better Understanding of the Mechanisms of Action of Histone Deacetylases Inhibitors to the Progress of the Treatment of Malignant Lymphomas an…

2017

Background Notable progress has been made in chemo- and immunotherapy of B-cell lymphomas, but less in the treatment of T-cell lymphomas. Objective Histone deacetylases inhibitors are a potentially useful therapeutic mean, as an epigenetic dysregulation is present in lymphomas, and especially in T-cell types. We aimed to study the progress made in this area. Method A mini-review was achieved using the articles published in PubMed in the last two years and the new patents made in this field. Results Histone deacetylases inhibitors are involved in the derepression of tumor suppressor genes through a histone deacetylase-mediated transcriptional process. Their inhibition is followed by cell cyc…

Cancer ResearchDrug exportmedicine.medical_treatmentCellular differentiationAntineoplastic Agents010402 general chemistryLymphoma T-Cell01 natural sciencesHistone DeacetylasesRomidepsinPatents as TopicDrug DiscoveryPlasma Cell MyelomamedicineAnimalsHumansPharmacology (medical)Epigeneticsbiology010405 organic chemistrybusiness.industryDrug SynergismGeneral MedicineImmunotherapymedicine.diseasePeripheral T-cell lymphoma0104 chemical sciencesHistone Deacetylase InhibitorsHistoneOncologyDrug DesignImmunologyCancer researchbiology.proteinbusinessMultiple Myelomamedicine.drugRecent patents on anti-cancer drug discovery
researchProduct

Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30

2010

Abstract Background To clarify the immunological alterations leading to classical Kaposi sarcoma (cKS) among people infected with KS-associated herpesvirus (KSHV). Methods In a population-based study of 119 cKS cases, 105 KSHV-seropositive controls, and 155 KSHV-seronegative controls, we quantified plasma soluble cluster of differentiation (sCD) levels and antibodies against Epstein-Barr virus nuclear antigen-1 (anti-EBNA-1) and viral capsid antigen (anti-VCA). Differences between groups in prevalence of low-tertile anti-EBNA-1 and high-tertile anti-VCA were compared by logistic regression. Continuous levels between groups and by presence of cKS co-factors among controls were compared by li…

Cancer ResearchEpidemiologyPopulationmedicine.disease_causeSettore MED/42 - Igiene Generale E Applicatalcsh:RC254-282Viruslcsh:Infectious and parasitic diseasesDiabetes mellitusmedicinelcsh:RC109-216educationeducation.field_of_studyEpstein-Barr virus antibodiebiologyCluster of differentiationbusiness.industryKaposi sarcomasCD26 sCD23 and sCD30lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseEpstein–Barr virusInfectious DiseasesOncologyImmunologyKaposi sarcoma; Epstein-Barr virus antibodies; sCD26 sCD23 and sCD30biology.proteinSarcomaCortisoneAntibodybusinessmedicine.drugResearch ArticleInfectious Agents and Cancer
researchProduct

Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications.

2004

Cathepsin D is a lysosomal acid proteinase which is involved in the malignant progression of breast cancer and other gynecological tumors. Clinical investigations have shown that in breast cancer patients cathepsin D overexpression was significantly correlated with a shorter free-time disease and overall survival, whereas in patients with ovarian or endometrial cancer this phenomenon was associated with tumor aggressiveness and a degree of chemoresistance to various antitumor drugs such as anthracyclines, cis-platinum and vinca alkaloids. Therefore, a lot of research has been undertaken to evaluate the role and the prognostic value of cathepsin D also in other solid neoplasms. However, conf…

Cancer ResearchPathologymedicine.medical_specialtyLung NeoplasmsSkin NeoplasmsCathepsin DAntineoplastic AgentsBiologyDigestive System NeoplasmsCathepsin DMetastasisCentral Nervous System NeoplasmsBreast cancerSurgical oncologyNeoplasmsmedicineBiomarkers TumorNeoplasmHumansClinical significanceThyroid NeoplasmsMelanomaEndometrial cancerGeneral Medicinecathepsin D lysosomal proteinases matrix-metalloproteinases metastasis neoplasm plasminogen activator prognosis tumor progressionmedicine.diseaseNeoplasm ProteinsOncologyTumor progressionHead and Neck NeoplasmsDrug DesignCancer researchDisease ProgressionLysosomesUrogenital NeoplasmsClinicalexperimental metastasis
researchProduct

Partial restoration of pre-transformation levels of lysyl oxidase and transin mRNAs in phenotypic ras revertants.

1995

Neoplastic transformation mediated by ras oncogenes is associated with deregulated expression of genes encoding, for example, various proteases, lysyl oxidase, and smooth-muscle α-actin. To define the role of these genes in the initiation or maintenance of the ras-transformed state, we compared their steady-state mRNA levels in two different sets of preneoplastic fibroblast lines, ras-transformed clones, and phenotypic revertants derived from them. Compared with the preneoplastic fibroblasts, the ras-transformed derivatives exhibited elevated levels of cathepsin L (major excreted protein), transin (stromelysin I, matrix metalloproteinase–3), and collagenase I (matrix metalloproteinase–1) mR…

Cancer ResearchTranscription GeneticCathepsin LBlotting WesternGene ExpressionLysyl oxidaseCell LineCathepsin LProtein-Lysine 6-OxidaseProto-Oncogene Proteins c-mycDownregulation and upregulationEndopeptidasesmedicineAnimalsNeoplastic transformationCollagenasesRNA MessengerFibroblastMolecular BiologyGeneMessenger RNAbiologyMetalloendopeptidasesPhenotypeMolecular biologyCathepsinsNeoplasm ProteinsRatsCysteine Endopeptidasesmedicine.anatomical_structureCell Transformation NeoplasticGenes rasPhenotypebiology.proteinMatrix Metalloproteinase 3Matrix Metalloproteinase 1Precancerous ConditionsMolecular carcinogenesis
researchProduct

Abstract 2370: Elevated levels of anti-Epstein Barr virus (EBV) antibodies in EBV-associated gastric carcinoma

2020

Abstract Background: Almost 10% of gastric carcinomas contain Epstein-Barr virus (EBV) DNA, which is not found in other gastrointestinal tract cancers. EBV-positive tumors have distinct clinico-epidemiologic features and are molecularly characterized by recurrent PIK3CA and absent TP53 mutations, JAK2 and PD-L1/L2 amplifications, and extreme DNA hypermethylation. Identification of the gastric cancer-specific antibody response to this common infection may elucidate its contribution to carcinogenesis and provide a non-invasive method to detect EBV-positive gastric tumors. Methods: Plasma samples from Latvian patients with EBV-positive (n=28) and -negative (n=34) gastric cancer were immune-pro…

Cancer Researchbiologybusiness.industryCancermedicine.disease_causemedicine.diseaseEpstein–Barr virusVirusSerologyOncologyNasopharyngeal carcinomaAntigenhemic and lymphatic diseasesImmunologybiology.proteinmedicineAntibodybusinessCarcinogenesisCancer Research
researchProduct

Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review).

2008

It has been shown that epigenetic modifications play an important role in tumorigenesis. Thus, affecting epigenetic tumorigenic alterations can represent a promising strategy for anticancer targeted therapy. Among the key chromatin modifying enzymes which influence gene expression, histone acetyltransferases (HATs) and histone deacetylases (HDACs) have recently attracted interest because of their impact on tumor development and progression. Increased expression of HDACs and disrupted activities of HATs have been found in several tumor types, with a consequent hypoacetylated state of chromatin that can be strictly correlated with low expression of either tumor suppressor or pro-apoptotic gen…

Cancer Researchmedicine.drug_classAntineoplastic AgentsApoptosisBiologyHydroxamic AcidsModels BiologicalRomidepsinEpigenesis Geneticchemistry.chemical_compoundDepsipeptidesNeoplasmsSettore BIO/10 - BiochimicamedicineHumansEpigeneticsVorinostatSulfonamidesVorinostatHistone deacetylase inhibitorHDACI apoptosisChromatinChromatinProtein Structure TertiaryGene Expression Regulation NeoplasticHistone Deacetylase InhibitorsHistoneOncologychemistryModels ChemicalCancer researchbiology.proteinHistone deacetylaseBelinostatmedicine.drug
researchProduct